Organ transplantation research hub

Immunosuppressive drug bioequivalence in kidney transplant recipients – Prograf and CellCept

This study looks at how well different versions of medicines (Prograf and CellCept) used after a kidney transplant are absorbed by the body. It helps make sure new versions work just as well as existing ones to protect your new kidney.